In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.
The test detects and quantifies hepatitis C virus RNA and can be performed in approximately one hour.
FIND will lead evaluation studies in Cameroon and Georgia between September 2018 and May 2019 to confirm the assay's diagnostic accuracy and commercial utility.
The firm's diagnostics division was up 4 percent. Molecular diagnostics grew 7 percent, cytology & perinatal was flat, and blood screening was down 2 percent.
Public sector programs in some low- and middle-income countries will obtain access to Hologic's Panther system through a single, all-inclusive pricing structure.
An RNA test in development that confirms whether a patient has HCV within 40 minutes could enable diagnosis and prescribing treatment during a single office visit.
The company said the disposal of these two businesses is part of a strategy to focus entirely on the molecular diagnostics market.
The firm showed 98 percent sensitivity and 100 percent specificity across all major HCV genotypes in a recent study.
The device is expected to be used with Genedrive's hepatitis C virus assay, which recently received CE-IVD marking.
The alliance follows a marketing deal signed with Sysmex Europe that covers Europe, the Middle East, and Africa.
This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.
The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.
Researchers find that people's genetics influence their success at university, but that it is not the only factor.
In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.